Compound Detail
CHEMBL131819
TAZOMELINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL131819 |
| Name | TAZOMELINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | XUHMGFKQBWZWPO-UHFFFAOYSA-N |
1
Targets
3
Activities
1
Assay Types
0
PK Parameters
1
Publications
3
Known Names
Molecular Properties
297.5
MW (Da)
3.93
ALogP
5
HBA
0
HBD
29.0
PSA (Ų)
0.56
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Activity Summary
IC50 3 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Muscarinic acetylcholine receptor M1 CHEMBL276 | IC50 | 8.3 | 8.245 | 5.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Muscarinic acetylcholine receptor M1 | IC50 | = | 5.0 | nM | 8.3 | Displacement of [3H]pirenzepine (Pz) from rat hippocampus muscarinic acetylcholi... | 1433209 |
| Muscarinic acetylcholine receptor M1 | IC50 | = | 6.5 | nM | 8.19 | Displacement of [3H]oxotremorine-M (Oxo-M) from rat hippocampus muscarinic acety... | 1433209 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1433209 | 10.1021/jm00100a005 | Muscarinic acetylcholine receptor M1 | 4 |
Data from ChEMBL 36 via Core Engine